Angiotensin II Acetate 50 µg/vial (Clinalfa basic)

U-1050

A considerable number of publications on Clinalfa products used in clinical trials are available. The most important publications are listed below. For a comprehensive list please contact us.

 

All information is compiled to the best of our knowledge. We cannot be made liable for any possible errors or misprints.

Clinalfa

Literature references citing the Clinalfa basic product

2013

van Twist, D. J., Houben, A. J., de Haan, M. W., Mostard, G. J., Kroon, A. A. and de Leeuw, P. W.
Angiotensin-(1-7)-induced renal vasodilation in hypertensive humans is attenuated by low sodium intake and angiotensin II co-infusion.
Hypertension 62, 789-793 (2013)
Abstract

 

2006

Boschmann, M., Adams, F., Schaller, K., Franke, G., Sharma, A. M., Klaus, S., Luft, F. C. and Jordan, J.
Hemodynamic and metabolic responses to interstitial angiotensin II in normal weight and obese men.
J. Hypertens. 24, 1165-1171 (2006)
Abstract

Houben, A. J., Burgwinkel, J. P. and de Leeuw, P. W.
A novel approach to the study of human microcirculation: Reactivity to locally applied angiotensin II in the conjunctival microvascular bed.
J. Hypertens. 24, 2225-2230 (2006)
Abstract

Luther, J. M., Gainer, J. V., Murphey, L. J., Yu, C., Vaughan, D. E., Morrow, J. D. and Brown, N. J.
Angiotensin II induces interleukin-6 in humans through a mineralocorticoid receptor-dependent mechanism.
Hypertension 48, 1050-1057 (2006)
Abstract

Morgan, D. R., Dixon, L. J., Hanratty, C. G., El-Sherbeeny, N., Hamilton, P. B., McGrath, L. T., Leahey, W. J., Johnston, G. D. and McVeigh, G. E.
Effects of dietary omega-3 fatty acid supplementation on endothelium-dependent vasodilation in patients with chronic heart failure.
Am. J. Cardiol. 97, 547-551 (2006)
Abstract

Schachinger, H., Klarhofer, M., Linder, L., Drewe, J. and Scheffler, K.
Angiotensin II decreases the renal MRI blood oxygenation level-dependent signal.
Hypertension 47, 1062-1066 (2006)
Abstract

 

2005

Bleeker, M. W., Kooijman, M., Rongen, G. A., Hopman, M. T. and Smits, P.
Preserved contribution of nitric oxide to baseline vascular tone in deconditioned human skeletal muscle.
J. Physiol. 565, 685-694 (2005)
Abstract

Hasler, C., Nussberger, J., Maillard, M., Forclaz, A., Brunner, H. R. and Burnier, M.
Sustained 24-hour blockade of the renin-angiotensin system: a high dose of a long-acting blocker is as effective as a lower dose combined with an angiotensin-converting enzyme inhibitor.
Clin. Pharmacol. Ther. 78, 501-507 (2005)
Abstract

Kistler, P. M., Davidson, N. C., Sanders, P., Fynn, S. P., Stevenson, I. H., Spence, S. J., Vohra, J. K., Sparks, P. B. and Kalman, J. M.
Absence of acute effects of angiotensin II on atrial electrophysiology in humans.
J. Am. Coll. Cardiol. 45, 154-156 (2005)
Abstract

 

2004

Fleischmann, E. H., John, S., Delles, C., Schneider, M. P., Schmidt, B. M. and Schmieder, R. E.
The effect of statins on angiotensin II-induced hemodynamic changes in young, mildly hypercholesterolemic men.
Am. J. Hypertens. 17, 1120-1126 (2004)
Abstract

Gossl, M., Mitchell, A., Lerman, A., Opazo Saez, A., Schafers, R. F., Erbel, R., Philipp, T. and Wenzel, R. R.
Endothelin-B-receptor-selective antagonist inhibits endothelin-1 induced potentiation on the vasoconstriction to noradrenaline and angiotensin II.
J. Hypertens. 22, 1909-1916 (2004)
Abstract

Mitchell, A., Luckebergfeld, B., Buhrmann, S., Rushentsova, U., Nurnberger, J., Siffert, W., Schafers, R. F., Philipp, T. and Wenzel, R. R.
Effects of systemic endothelin A receptor antagonism in various vascular beds in men: in vivo interactions of the major blood pressure-regulating systems and associations with the GNB3 C825T polymorphism.
Clin. Pharmacol. Ther. 76, 396-408 (2004)
Abstract

Morgan, D. R., Dixon, L. J., Hanratty, C. G., Hughes, S. M., Leahey, W. J., Rooney, K. P., Johnston, G. D. and McVeigh, G. E.
Impaired endothelium-dependent and -independent vasodilation in elderly patients with chronic heart failure.
Eur. J. Heart Fail. 6, 901-908 (2004)
Abstract

Sim, J. S., Dick, J. B. and Struthers, A. D.
Statin therapy increases vascular sensitivity to angiotensin II in hypercholesterolaemic patients.
J. Renin. Angiotensin Aldosterone Syst. 5, 109-113 (2004)
Abstract

Spaanderman, M. E., Ekhart, T. H., de Leeuw, P. W. and Peeters, L. L.
Angiotensin II sensitivity in nonpregnant formerly preeclamptic women and healthy parous controls.
J. Soc. Gynecol. Investig. 11, 416-422 (2004)
Abstract

 

2003

Boschmann, M., Jordan, J., Adams, F., Christensen, N. J., Tank, J., Franke, G., Stoffels, M., Sharma, A. M., Luft, F. C. and Klaus, S.
Tissue-specific response to interstitial angiotensin II in humans.
Hypertension 41, 37-41 (2003)
Abstract

Helmy, A., Newby, D. E., Jalan, R., Johnston, N. R., Hayes, P. C. and Webb, D. J.
Nitric oxide mediates the reduced vasoconstrictor response to angiotensin II in patients with preascitic cirrhosis.
J. Hepatol. 38, 44-50 (2003)
Abstract

Lottermoser, K., Unger, T., Gohlke, P., Vetter, H. and Dusing, R.
Differential effect of acute angiotensin II type 1 receptor blockade on the vascular and adrenal response to exogenous angiotensin II in humans.
Am. J. Hypertens. 16, 445-452 (2003)
Abstract

Millasseau, S. C., Kelly, R. P., Ritter, J. M. and Chowienczyk, P. J.
The vascular impact of aging and vasoactive drugs: comparison of two digital volume pulse measurements.
Am. J. Hypertens. 16, 467-472 (2003)
Abstract

Miller, J. A., Curtis, J. R. and Sochett, E. B.
Relationship between diurnal blood pressure, renal hemodynamic function, and the renin-angiotensin system in type 1 diabetes.
Diabetes 52, 1806-1811 (2003)
Abstract

Pleiner, J., Mittermayer, F., Schaller, G., Marsik, C., MacAllister, R. J. and Wolzt, M.
Inflammation-induced vasoconstrictor hyporeactivity is caused by oxidative stress.
J. Am. Coll. Cardiol. 42, 1656-1662 (2003)
Abstract

Vittorio, T. J., Lang, C. C., Katz, S. D., Packer, M., Mancini, D. M. and Jorde, U. P.
Vasopressor response to angiotensin II infusion in patients with chronic heart failure receiving beta-blockers.
Circulation 107, 290-293 (2003)
Abstract

 

2002

de Haas, S. L., Wilkinson, I. B., Boyd, J. L. and Webb, D. J.
Local nitric oxide release does not affect tachyphylaxis to angiotensin II in dorsal hand veins in man in the presence of prostaglandin synthesis inhibition.
Br. J. Clin. Pharmacol. 53, 193-195 (2002)
Abstract

Farquharson, C. A. and Struthers, A. D.
Aldosterone induces acute endothelial dysfunction in vivo in humans: evidence for an aldosterone-induced vasculopathy.
Clin. Sci. (Lond) 103, 425-431 (2002)
Abstract

Jorde, U. P., Vittorio, T., Katz, S. D., Colombo, P. C., Latif, F. and Le Jemtel, T. H.
Elevated plasma aldosterone levels despite complete inhibition of the vascular angiotensin-converting enzyme in chronic heart failure.
Circulation 106, 1055-1057 (2002)
Abstract

Rehman, A., Rahman, A. R. and Rasool, A. H.
Effect of angiotensin II on pulse wave velocity in humans is mediated through angiotensin II type 1 (AT(1)) receptors.
J. Hum. Hypertens. 16, 261-266 (2002)
Abstract

Schou, M., Gabrielsen, A., Bruun, N. E., Skott, P., Pump, B., Dige-Petersen, H., Frandsen, E., Bie, P., Warberg, J., Christensen, N. J. and Norsk, P.
Angiotensin II attenuates the natriuresis of water immersion in humans.
Am. J. Physiol. Regul. Integr. Comp. Physiol. 283, R187-196 (2002)
Abstract

van der Kleij, F. G., de Jong, P. E., Henning, R. H., de Zeeuw, D. and Navis, G.
Enhanced responses of blood pressure, renal function, and aldosterone to angiotensin I in the DD genotype are blunted by low sodium intake.
J. Am. Soc. Nephrol. 13, 1025-1033 (2002)
Abstract

Wenzel, R. R., Siffert, W., Bruck, H., Philipp, T. and Schafers, R. F.
Enhanced vasoconstriction to endothelin-1, angiotensin II and noradrenaline in carriers of the GNB3 825T allele in the skin microcirculation.
Pharmacogenetics 12, 489-495 (2002)
Abstract

Wilkinson, I. B., Affolter, J. T., de Haas, S. L., Pellegrini, M. P., Boyd, J., Winter, M. J., Balment, R. J. and Webb, D. J.
High plasma concentrations of human urotensin II do not alter local or systemic hemodynamics in man.
Cardiovasc. Res. 53, 341-347 (2002)
Abstract

 

2001

Berlowitz, M. S., Latif, F., Hankins, S. R., Ennezat, P. V., Moskowitz, R., Tandon, S., Colombo, P. C. and Le Jemtel, T. H.
Dose-dependent blockade of the angiotensin II type 1 receptor with losartan in normal volunteers.
J. Cardiovasc. Pharmacol. 37, 692-696 (2001)
Abstract

Hilgers, K. F., Delles, C., Veelken, R. and Schmieder, R. E.
Angiotensinogen gene core promoter variants and non-modulating hypertension.
Hypertension 38, 1250-1254 (2001)
Abstract

Kelly, R. P., Millasseau, S. C., Ritter, J. M. and Chowienczyk, P. J.
Vasoactive drugs influence aortic augmentation index independently of pulse-wave velocity in healthy men.
Hypertension 37, 1429-1433 (2001)
Abstract

Petrie, M. C., McDonald, J. E., Hillier, C., Morton, J. J. and McMurray, J. J.
Effects of adrenomedullin on angiotensin II stimulated atrial natriuretic peptide and arginine vasopressin secretion in healthy humans.
Br. J. Clin. Pharmacol. 52, 165-168 (2001)
Abstract

Rehman, A., Rahman, A. R., Rasool, A. H. and Naing, N. N.
The effects of angiotensin II on pulse wave velocity in healthy humans.
Int. J. Clin. Pharmacol. Ther. 39, 423-430 (2001)
Abstract

Troughton, R. W., Frampton, C. M., Lewis, L. K., Yandle, T. G., Richards, A. M. and Nicholls, M. G.
Differing thresholds for modulatory effects of adrenomedullin infusion on haemodynamic and hormone responses to angiotensin II and adrenocorticotrophic hormone in healthy volunteers.
Clin. Sci. (Lond) 101, 103-109 (2001)
Abstract

Wenzel, R. R., Ruthemann, J., Bruck, H., Schafers, R. F., Michel, M. C. and Philipp, T.
Endothelin-A receptor antagonist inhibits angiotensin II and noradrenaline in man.
Br. J. Clin. Pharmacol. 52, 151-157 (2001)
Abstract

Wilkinson, I. B., MacCallum, H., Hupperetz, P. C., van Thoor, C. J., Cockcroft, J. R. and Webb, D. J.
Changes in the derived central pressure waveform and pulse pressure in response to angiotensin II and noradrenaline in man.
J. Physiol. 530, 541-550 (2001)
Abstract

 

2000

Farquharson, C. A. and Struthers, A. D.
Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failure.
Circulation 101, 594-597 (2000)
Abstract

Freudenthaler, S. M., Lucht, I., Schenk, T., Brink, M. and Gleiter, C. H.
Dose-dependent effect of angiotensin II on human erythropoietin production.
Pflugers Arch. 439, 838-844 (2000)
Abstract

Helmy, A., Jalan, R., Newby, D. E., Hayes, P. C. and Webb, D. J.
Role of angiotensin II in regulation of basal and sympathetically stimulated vascular tone in early and advanced cirrhosis.
Gastroenterology 118, 565-572 (2000)
Abstract

Kraiczi, H., Hedner, J., Peker, Y. and Carlson, J.
Increased vasoconstrictor sensitivity in obstructive sleep apnea.
J. Appl. Physiol. 89, 493-498 (2000)
Abstract

Labinjoh, C., Newby, D. E., Dawson, P., Johnston, N. R., Ludlam, C. A., Boon, N. A. and Webb, D. J.
Fibrinolytic actions of intra-arterial angiotensin II and bradykinin in vivo in man.
Cardiovasc. Res. 47, 707-714 (2000)
Abstract

Larsson, P. T., Schwieler, J. H. and Wallen, N. H.
Platelet activation during angiotensin II infusion in healthy volunteers.
Blood Coagul. Fibrinolysis 11, 61-69 (2000)
Abstract

Lee, A. F., McFarlane, L. C. and Struthers, A. D.
Ovarian hormones in man: their effects on resting vascular tone, angiotensin converting enzyme activity and angiotensin II-induced vasoconstriction.
Br. J. Clin. Pharmacol. 50, 73-76 (2000)
Abstract

Maillard, M. P., Rossat, J., Nussberger, J., Ramis, J., Pontes, C., Burnier, M. and Brunner, H. R.
Pharmacologic profile of UR-7247, an orally active angiotensin II AT1 receptor antagonist, in healthy volunteers. p6.
J. Cardiovasc. Pharmacol. 35, 383-389 (2000)
Abstract

Petrie, M. C., Hillier, C., Morton, J. J. and McMurray, J. J.
Adrenomedullin selectively inhibits angiotensin II-induced aldosterone secretion in humans.
J. Hypertens. 18, 61-64 (2000)
Abstract

Saris, J. J., van Dijk, M. A., Kroon, I., Schalekamp, M. A. and Danser, A. H.
Functional importance of angiotensin-converting enzyme-dependent in situ angiotensin II generation in the human forearm.
Hypertension 35, 764-768 (2000)
Abstract

Ueda, S., Masumori-Maemoto, S., Ashino, K., Nagahara, T., Gotoh, E., Umemura, S. and Ishii, M.
Angiotensin-(1-7) attenuates vasoconstriction evoked by angiotensin II but not by noradrenaline in man.
Hypertension 35, 998-1001 (2000)
Abstract

 

1999

Anumba, D. O., Robson, S. C., Boys, R. J. and Ford, G. A.
Nitric oxide activity in the peripheral vasculature during normotensive and preeclamptic pregnancy.
Am. J. Physiol. 277, H848-854 (1999)
Abstract

 

1998

Newby, D. E., Goodfield, N. E., Flapan, A. D., Boon, N. A., Fox, K. A. and Webb, D. J.
Regulation of peripheral vascular tone in patients with heart failure: contribution of angiotensin II.
Heart 80, 134-140 (1998)
Abstract

Newby, D. E., Jalan, R., Masumori, S., Hayes, P. C., Boon, N. A. and Webb, D. J.
Peripheral vascular tone in patients with cirrhosis: role of the renin-angiotensin and sympathetic nervous systems.
Cardiovasc. Res. 38, 221-228 (1998)
Abstract